Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

L'Oreal FY11 Profit Rises - Quick Facts

L'Oreal SA (LRLCY.PK) Monday reported an increase in profit for the full-year 2011, as sales and gross margins improved.

Net profit excluding non-recurring items after non-controlling interests for the full-year 2011 improved to 2.58 billion euros or 4.32 euro per share from 2.37 billion euros or 4.01 euro per share last year.

Net profit after non-controlling interests for the period was 2.44 billion euros or 4.08 euro per share compared to 2.24 billion euros or 3.79 euro per share last year.

Sales for the full-year rose to 20.34 billion euros from 19.50 billion euros last year. On a like-for-like basis, sales for the year increased 5.1 percent from last year.

Full-year gross margin advanced 40 basis points to 71.2 percent.

Click here to receive FREE breaking news email alerts for L'Oreal Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Fashion retailer Gap Inc. said Thursday after the markets closed that its second quarter profit rose 10% from last year, helped by higher sales and a gain from asset sale. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarter sales. Separately, Gap announced plans to enter India through franchise-operated Gap brand stores in 2015. While buying interest was somewhat subdued, stocks moved mostly higher over the course of the trading day on Thursday. The gains on the day extended the recent upward trend by the markets, lifting the S&P 500 to a new record closing high. Republicans have not found much to like about President Barack Obama's nearly six years in office, but the results of a new Washington Post-ABC News poll show that a vast majority support the president's decision to launch airstrikes in Iraq.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.